A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas-Reference-Cited by-同舟云学术

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

Published:2013-08-08 Issue:1 Volume:163 Page:55-61
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Evens Andrew M.¹,Rosen Steven T.²,Helenowski Irene³,Kline Justin⁴,Larsen Annette⁵,Colvin Jennifer⁵,Winter Jane N.²,van Besien Koen M.⁶,Gordon Leo I.²,Smith Sonali M.⁴

Affiliation:

1. Division of Hematology/Oncology; Tufts University School of Medicine; Boston; MA; USA

2. Division of Hematology/Oncology; Robert H. Lurie Comprehensive Cancer Center; Feinberg School of Medicine; Northwestern University; Chicago; IL; USA

3. Department of Preventive Medicine; Northwestern University; Chicago; IL; USA

4. Section of Hematology/Oncology; University of Chicago; Chicago; IL; USA

5. Cancer Research Office; The University of Massachusetts Medical School; Worcester; MA; USA

6. Division of Hematology; Cornell School of Medicine; New York; NY; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12488/fullpdf

Reference40 articles.

1. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience;Arkenau;Haematologica,2007

2. Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer;Awasthi;HPB (Oxford),2009

3. Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer;Awasthi;Cancer Biology & Therapy,2010

4. Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors;Bommakanti;American Journal of Clinical Oncology,2011

5. Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells;Ceresa;Molecular Cancer Therapeutics,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas;Haematologica;2023-11-21

2. Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin-Based Theranostics Composition;Molecules;2023-03-15

3. Clinical Experience on Proteasome Inhibitors in Cancer;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

4. Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders;Cancers;2022-05-18

5. Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells;Cancer Biology & Therapy;2022-03-25